Skip to main content
logo
Agios Pharmaceuticals, Inc. (LON:0HB0)
London flag London · Delayed Price · Currency is GBP · Price in USD
42.46
+0.22 (0.52%)
At close: Oct 20, 2025

Agios Pharmaceuticals Revenue

Agios Pharmaceuticals had revenue of $12.46M USD in the quarter ending June 30, 2025, with 44.57% growth. This brings the company's revenue in the last twelve months to $40.88M, up 30.57% year-over-year. In the year 2024, Agios Pharmaceuticals had annual revenue of $36.50M with 36.07% growth.

Revenue (ttm)
$40.88M
Revenue Growth
+30.57%
P/S Ratio
61.53
Revenue / Employee
$83.76K
Employees
488
Market Cap
1.84B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202436.50M9.68M36.07%
Dec 31, 202326.82M12.58M88.36%
Dec 31, 202214.24M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca41.24B
GSK plc31.63B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
ConvaTec Group1.72B
Spire Healthcare Group1.55B
Genus672.80M
Revenue Rankings

Agios Pharmaceuticals News

More News